Pfg Investments, LLC Aldeyra Therapeutics, Inc. Transaction History
Pfg Investments, LLC
- $1.61 Trillion
- Q4 2024
A detailed history of Pfg Investments, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 347,747 shares of ALDX stock, worth $2.14 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
347,747
Previous 386,447
10.01%
Holding current value
$2.14 Million
Previous $2.08 Billion
16.69%
% of portfolio
0.11%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding ALDX
# of Institutions
127Shares Held
37.6MCall Options Held
757KPut Options Held
539K-
Perceptive Advisors LLC New York, NY9.28MShares$57 Million1.54% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$33.7 Million17.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$23.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$22.3 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.47MShares$9.03 Million0.17% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $359M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...